Cited by 29Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19Viral Infections and Immunology Research

Natural course of chronic fatigue syndrome/myalgic encephalomyelitis in adolescents

Open access
Norris, Tom, Collin, Simon M, Tilling, Kate, Nuevo, Roberto, Stansfeld, Stephen A, Sterne, Jonathan AC, Heron, Jon, Crawley, Esther·2017·Archives of Disease in Childhood

Abstract

Objective: Little is known about persistence of or recovery from chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in adolescents. Previous studies have small sample sizes, short follow-up or have focused on fatigue rather than CFS/ME or, equivalently, chronic fatigue, which is disabling. This work aimed to describe the epidemiology and natural course of CFS/ME in adolescents aged 13–18 years. Design: Longitudinal follow-up of adolescents enrolled in the Avon Longitudinal Study of Parents and Children. Setting: Avon, UK. Participants: We identified adolescents who had disabling fatigue of >6 months duration without a known cause at ages 13, 16 and 18 years. We use the term ‘chronic disabling fatigue’ (CDF) because CFS/ME was not verified by clinical diagnosis. We used multiple imputation to obtain unbiased estimates of prevalence and persistence. Results: The estimated prevalence of CDF was 1.47% (95% CI 1.05% to 1.89%) at age 13, 2.22% (1.67% to 2.78%) at age 16 and 2.99% (2.24% to 3.75%) at age 18. Among adolescents with CDF of 6 months duration at 13 years 75.3% (64.0% to 86.6%) were not classified as such at age 16. Similar change was observed between 16 and 18 years (75.0% (62.8% to 87.2%)). Of those with CDF at age 13, 8.02% (0.61% to 15.4%) presented with CDF throughout the duration of adolescence. Conclusions: The prevalence of CDF lasting 6 months or longer (a proxy for clinically diagnosed CFS/ME) increases from 13 to 18 years. However, persistent CDF is rare in adolescents, with approximately 75% recovering after 2–3 years.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/archdischild-2016-311198

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [6]National Institute for Health and Care Excellence (NICE). Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (NICE clinical guideline CG53). London, 2007. 31851438

Cited by

Sorted by citations

Authors
Norris, T., Collin, S. M., Tilling, K., Nuevo, R., Stansfeld, S. A., Sterne, J. A., Heron, J., & Crawley, E.
Affiliations
  • University of Bristol (GB)
  • Instituto de Salud Carlos III (ES)
  • Queen Mary University of London (GB)
Corresponding author
Crawley, Esther
Venue
Archives of Disease in Childhood
Publisher
BMJ
Published
2017-01-19
Volume
102
Issue
6
Pages
522-528
ISSN
  • 0003-9888 (ISSN-L)
  • 1468-2044
OpenAlex
W2574430848
Cited by
29
References
41
Citations by year
2026: 1 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 4 · 2019: 8 · 2018: 6 · 2017: 2
FWCI
3.60
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of Disease in Childhood (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion, cc-by)
  • Figshare (submittedVersion, cc-by)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
  • HighWire Press Open Archive (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
Funders
Medical Research Council (MR/K020269/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
Keywords
chronic fatigue syndrome, adolescents, natural history (disease), disease persistence, recovery, prevalence, longitudinal follow-up, Avon Longitudinal Study of Parents and Children
MeSH terms
Adolescent, Educational Status, England, Female, Follow-Up Studies, Humans, Male, Prognosis, Time Factors, Fatigue Syndrome, Chronic, Prevalence, Sex Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review